Overview Benefits Service Specs Technical Information Publication How to Order |
At HySigen Biosciences, Our Custom Vector Construction Service are engineered to support the diverse needs of the global scientific community—from academic laboratories to large-scale biopharma enterprises. We deliver high-quality plasmid DNA with 100% sequence accuracy of the insert, guaranteeing your required yield (from μg to g scale) regardless of the plasmid type.
We offer a versatile range of production scales and quality grades, providing tailored solutions for your specific applications. Our comprehensive Quality Control (QC) suite supports everything from foundational research to advanced animal studies. With extensive expertise in downstream applications—including mRNA, AAV, and Lentiviral plasmids—we specialize in navigating complex structures like long poly(A) tails and ITR sequences.
Whether you require de novo plasmid preparation or scaling up a previously synthesized construct, our platform offers instant quoting. Partner with HySigen Biosciences for precision, reliability, and excellence. Place your order today.
Service Details
Services | Gene Editing / Overexpression / RNA Interference / Customized Services |
Vectors | Lentiviral / Adeno-Associated Viral (AAV) / Transposon Vector / Customized Vector |
Deliverables | Plasmids / Plasmid map / Plasmid sequencing results |
Turnaround/Price |
Service Details
Homogeneity | Specification |
Quantity | Depends on your choice |
Endotoxin Level | Depends on your choice |
Appearance | Clear, colorless, and free from precipitates or foreign particles |
A260/230; A260/280 | A260/230 ≥2 ; A260/280: 1.8-2.0 |
Sequence Accuracy | 100% alignment with reference sequence |
Residual RNA | Not visible on agarose gel |
E.coli Genomic DNA | < 15% by agarose gel electrophoresis |
Please Note
1.Quality Assessment: While a specific supercoiled content is not guaranteed, agarose gel electrophoresis (AGE) will be performed as part of our standard quality assessment protocol. Historical data indicates that over 80% of our prepared plasmids achieve a supercoiled content exceeding 80%.
2.Sequence Verification: Sequence verification is performed exclusively for the insert region. Full-plasmid sequencing services are available for an additional fee.
3.Residual E. coli Genomic DNA (gDNA): Residual E. coli genomic DNA is <15% as determined by agarose gel electrophoresis. This indicates that the intensity of the gDNA band is less than 15% of the total intensity of all bands present on the gel.

100% Sequence Accuracy Guarantee
Full-length sequence verification for all inserts and custom constructs
Customizable Yields: μg to g Scale
Flexible production volumes tailored to your specific project requirements
Versatile Grades for Every Application
Comprehensive QC options supporting everything from basic R&D to in vivo animal studies
Specialized in Complex Sequences
Expert handling of high-complexity motifs, including GC-rich regions, repetitive sequences, and long Poly(A) tails.
IF=23.2 Ma P, Guo J, Peng L, et al. PD-1-engineered manganese-based nanoplatform loaded with CXCL9 induces ICD and intensifies T-cell infiltration for melanoma treatment[J]. Advanced Composites and Hybrid Materials, 2025, 8(3): 242.
IF=19.5 Chen C Y, Wang Z, Hong C G, et al. Brain neuron-derived WDFY1 induces bone loss[J]. Nature Aging, 2026: 1-20.
IF=15.4 Mei Q, Zhang Y, Li H, et al. Hepatic factor MANF drives hepatocytes reprogramming by detaining cytosolic CK19 in intrahepatic cholangiocarcinoma[J]. Cell Death & Differentiation, 2025: 1-19.
IF=14.1 Kong X, Gu H, Zhang Y, et al. β‐Mangostin Attenuates TET2‐Mediated DNA Demethylation of Prkcg in the Prevention of Intervertebral Disc Degeneration[J]. Advanced Science, e05077.
IF=12.9 Zhu L, Tang Z, Jiang W, et al. Cholesterol biosynthesis induced by radiotherapy inhibits cGAS–STING activation and contributes to colorectal cancer treatment resistance[J]. Experimental & Molecular Medicine, 2025: 1-17.
IF=12.2 Li T, Wang H, Jiang Y, et al. LITTIP/Lgr6/HnRNPK complex regulates cementogenesis via Wnt signaling[J]. International Journal of Oral Science, 2023, 15(1): 33.
IF=10.2 Liao Z, Zhang L, Wu Z, et al. E0703 targets ERβ to facilitate the upregulation of GLI3, thereby alleviating irradiation-induced DNA damage on lymphocytes[J]. Cellular & Molecular Biology Letters, 2025, 30(1): 136.
IF=10.1 Li W, Ali T, Zheng C, et al. Anti-depressive-like behaviors of APN KO mice involve Trkb/BDNF signaling related neuroinflammatory changes[J]. Molecular Psychiatry, 2022, 27(2): 1047-1058.
100% Sequence Accuracy Guarantee
Full-length sequence verification for all inserts and custom constructs
Customizable Yields: μg to g Scale
Flexible production volumes tailored to your specific project requirements
Versatile Grades for Every Application
Comprehensive QC options supporting everything from basic R&D to in vivo animal studies
Specialized in Complex Sequences
Expert handling of high-complexity motifs, including GC-rich regions, repetitive sequences, and long Poly(A) tails.
Service Details
Services | Gene Editing / Overexpression / RNA Interference / Customized Services |
Vectors | Lentiviral / Adeno-Associated Viral (AAV) / Transposon Vector / Customized Vector |
Deliverables | Plasmids / Plasmid map / Plasmid sequencing results |
Turnaround/Price |
Service Details
Homogeneity | Specification |
Quantity | Depends on your choice |
Endotoxin Level | Depends on your choice |
Appearance | Clear, colorless, and free from precipitates or foreign particles |
A260/230; A260/280 | A260/230 ≥2 ; A260/280: 1.8-2.0 |
Sequence Accuracy | 100% alignment with reference sequence |
Residual RNA | Not visible on agarose gel |
E.coli Genomic DNA | < 15% by agarose gel electrophoresis |
Please Note
1.Quality Assessment: While a specific supercoiled content is not guaranteed, agarose gel electrophoresis (AGE) will be performed as part of our standard quality assessment protocol. Historical data indicates that over 80% of our prepared plasmids achieve a supercoiled content exceeding 80%.
2.Sequence Verification: Sequence verification is performed exclusively for the insert region. Full-plasmid sequencing services are available for an additional fee.
3.Residual E. coli Genomic DNA (gDNA): Residual E. coli genomic DNA is <15% as determined by agarose gel electrophoresis. This indicates that the intensity of the gDNA band is less than 15% of the total intensity of all bands present on the gel.

Promoter
The promoter is a fundamental element in any expression vector, responsible for initiating transcription of the downstream gene of interest (GOI). Selection of an appropriate promoter depends on the desired expression level and cellular or tissue specificity. Promoters can be ubiquitous (active in all cell types) or tissue-specific (active only in certain cell types). They also vary in strength—classified as weak, medium, or strong—which directly influences the amount of target gene expression.
Open Reading Frame (ORF)
The ORF corresponds to the coding sequence of the gene of interest, which is translated into a functional protein. Positioned downstream of the promoter, the ORF is central to the vector's purpose. When co-expression of multiple proteins is required, several ORFs can be placed under a single promoter and separated by specialized linkers, allowing them to be transcribed together as a polycistronic unit.
Polyadenylation Signal (polyA signal)
The polyA signal sequence ensures proper transcription termination and adds a poly(A) tail to the mRNA transcribed from the ORF. This polyadenylation stabilizes the mRNA by protecting it from degradation by cellular nucleases and phosphatases. It also facilitates nuclear export of the mRNA to the cytoplasm and promotes efficient translation by ribosomes.
Selection Marker
A selection marker allows researchers to identify and isolate cells that have successfully taken up the vector. Two common types are used in mammalian systems:
- Drug-selection markers confer resistance to a specific antibiotic, eliminating non-transfected cells.
- Fluorescent protein markers enable visual screening via fluorescence microscopy or isolation through fluorescence-activated cell sorting (FACS).
Origin of Replication
The origin of replication enables plasmid vectors to replicate inside bacterial host cells. Its choice determines the plasmid copy number per cell, which affects both plasmid stability and yield. High-copy-number origins are useful for maximizing DNA preparation yields, while low-copy-number origins are preferable when expressing toxic or insoluble proteins. For plasmid compatibility in bacterial co-culture, different plasmids must carry distinct origins of replication.
Antibiotic Resistance Gene
This gene allows selective growth of bacterial cells that harbor the vector by providing resistance to a specific antibiotic. Bacteria lacking the vector are sensitive to the antibiotic and are eliminated from the culture.
Other Components
While the components outlined above are common to most vector types, additional components may be included in specific vectors based on their intended applications.
For instance, viral vectors have distinct signature sequences: lentiviral vectors contain long terminal repeats (LTRs), while adeno-associated viral (AAV) vectors carry inverted terminal repeats (ITRs). Both sequences are critical for enabling virus-dependent expression of the gene(s) of interest (GOI) in target cells. Similarly, all transposon vectors harbor terminal repeat sequences, which are essential for transposase-mediated integration of the GOI into target cell genomes.
Beyond these essential elements, some vector components are non-essential for basic functionality but can greatly enhance vector versatility. A multiple cloning site (MCS), for example, is often integrated to introduce multiple restriction enzyme recognition sites, giving researchers the flexibility to clone their GOI using any of these sites. Linkers such as T2A and IRES are another such component—though not required for vector function, they allow the expression of multiple open reading frames (ORFs) as a polycistronic cassette from a single vector, thereby boosting the vector’s functional utility.

A critical step in designing any successful experiment is choosing an appropriate vector system for delivering your gene(s) of interest (GOI) into target cells. With a variety of viral and non‑viral systems available, it is important to evaluate several key factors before beginning vector design. Key considerations include:
Transfection efficiency – Are your target cells easy or difficult to transfect?
Expression profile – Do you need transient expression or stable genomic integration?
Promoter requirements – Should you use a customized promoter to drive your GOI?
Experimental context – Will the vector be used in cell culture or in vivo?
Regulatory control – Is conditional or inducible gene expression required?
Insert size – How large is your GOI?
The table below outlines commonly used vector systems and summarizes the main selection criteria to help guide your experimental design.
Regular plasmid vectors | Viral vectors | Transposon-based vectors | |
Transfection-based | Yes | No | Yes |
Transient expression or stable integration | Transient | Stable/Transient | Stable |
Requires packaging | No | Yes | No |
Cargo capacity | Large | Small-Medium | Medium-Large |
Primary use | Cell culture | Cell culture & In vivo | Cell culture &In vivo |
Promoter customization | Yes | Depending on type Yes | Yes |
Advantages
Technical simplicity: Regular plasmid vectors rely on straightforward transfection-based methods for delivering target genes into host cells. Conventional transfection of plasmid vectors is technically uncomplicated, which is far easier than virus-based vectors that require the packaging of live viruses.
Large cargo capacity: Regular plasmid vectors boast a large cargo capacity of approximately 30 kb. This offers ample space for incorporating various vector components, such as the user’s gene of interest (GOI), a promoter, and a marker—unlike most viral vectors, which have moderate to limited cargo capacity.
Disadvantages
Non-integration of vector DNA: Conventional plasmid transfection is also termed transient transfection, as the vector primarily exists as episomal DNA in cells without integration into the host genome. Nevertheless, plasmid DNA can permanently integrate into the host genome at an extremely low frequency (ranging from 1 per 102 to 106 cells, depending on the cell type). If a drug resistance or fluorescence marker is incorporated into the plasmid, stably transfected cells can be obtained through drug selection or cell sorting following prolonged culture.
Limited cell type range: Plasmid transfection efficiency varies significantly across different cell types. Non-dividing cells are generally more difficult to transfect than dividing cells, and primary cells are often less amenable to transfection than immortalized cell lines. Some critical cell types, such as neurons and pancreatic β cells, are notoriously hard to transfect. Additionally, plasmid transfection is mostly restricted to in vitro applications and rarely used in vivo.
Non-uniformity of gene delivery: While successful transfection can achieve a high average copy number of the plasmid vector per cell, the distribution is highly non-uniform. Some cells may harbor multiple copies, while others carry very few or none. This differs from viral vector-mediated transduction, which typically results in relatively uniform gene delivery into target cells.
Advantages
Broad Applicability: Viral vectors excel at transducing cells that are notoriously difficult to transfection (e.g., neurons, stem cells, and primary cells), including both dividing and non-dividing populations.
Versatile Delivery Platform: They are effective for gene delivery both in vitro (cell culture) and in vivo (live animals), overcoming a major limitation of plasmid vectors.
Uniform Gene Delivery: Viral transduction typically results in a more consistent number of vector copies delivered per cell compared to the often heterogeneous outcomes of standard transfection methods.
Key Considerations for Specific Vectors:
Lentivirus: Engineered with a VSV-G envelope to achieve broad tropism across mammalian species and diverse cell types, facilitating stable genomic integration.
Adeno-Associated Virus (AAV): Tissue specificity is determined by the capsid serotype used during packaging, allowing targeted transduction in vivo while maintaining a low immune response.
Disadvantages
Medium to small cargo capacity: Most viral vectors have limited cargo capacity compared to regular plasmids or transposon-based vectors. It is crucial to consider cargo capacity during viral vector design, as exceeding the vector’s capacity often impairs viral packaging efficiency. The table below outlines the upper genome size limit for different viral vectors and the consequences of oversized genomes.
Virus Type | Genomic Size Limit (5' to 3' ITR/LTR) | Effect of Exceeding Limit |
Adeno-associated virus (AAV) | 4.7 kb | Truncation and potential loss of function |
Adenovirus | 38.7 kb | Genomic instability and rearrangement |
Lentivirus | 9.2 kb | Reduced viral titer |
MMLV Retrovirus | 8 kb | Reduced viral titer |
MSCV Retrovirus | 8 kb | Reduced viral titer |
Technical Complexity: Production requires the generation of live virus in packaging cell lines and subsequent titer quantification—processes that are more technically demanding and time-consuming than simple plasmid transfection.
Viral Vector Types
Common viral vectors used in biomedical research include lentivirus, adeno-associated virus (AAV), and adenovirus, each with its own set of advantages and disadvantages. The table below summarizes key factors to consider when selecting the optimal viral vector for an experiment.
Feature | Lentivirus | AAV | Adenovirus |
Tropism | Broad | Serotype-dependent | Ineffective for some cells |
Infects Non-dividing Cells | Yes | Yes | Yes |
Expression | Stable integration | Transient (episomal) | Transient (episomal) |
Maximum Titer | High | High | Very High |
Promoter Customization | Yes | Yes | Yes |
Primary Application | Cell culture & in vivo | Predominantly in vivo | Predominantly in vivo |
Immune Response (in vivo) | Low | Very Low | High |
Advantages
Permanent integration of vector DNA: Transposon-based vectors are delivered into host cells using conventional transfection. While standard plasmid transfection typically results in transient DNA delivery (with DNA gradually lost over time, especially in rapidly dividing cells), transposon vectors—when co-transfected with a corresponding helper plasmid expressing the transposase enzyme—can mediate permanent integration of the transposon cassette into the host genome. This enables stable, long-term expression of the gene(s) of interest (GOI) in the target cells.
Technical simplicity: Like regular plasmids, transposon-based vectors are delivered via conventional transfection, which is technically straightforward. This avoids the complexity and specialized procedures associated with viral vector systems that require production and titration of live virus.
Disadvantages
Limited cell type range: Since transposon vector delivery depends on transfection efficiency, its applicability is constrained by the same cell-type limitations as regular plasmids. Transfection efficiency varies widely across cell types: non-dividing cells are often more difficult to transfect than dividing cells, and primary cells are typically less amenable than immortalized cell lines. Some important cell types, such as neurons and pancreatic β cells, are notoriously hard to transfect. Furthermore, plasmid-based transfection is largely restricted to in vitro use and is rarely employed in vivo, which limits the utility of transposon-based vector systems in certain experimental settings.
IF=23.2 Ma P, Guo J, Peng L, et al. PD-1-engineered manganese-based nanoplatform loaded with CXCL9 induces ICD and intensifies T-cell infiltration for melanoma treatment[J]. Advanced Composites and Hybrid Materials, 2025, 8(3): 242.
IF=19.5 Chen C Y, Wang Z, Hong C G, et al. Brain neuron-derived WDFY1 induces bone loss[J]. Nature Aging, 2026: 1-20.
IF=15.4 Mei Q, Zhang Y, Li H, et al. Hepatic factor MANF drives hepatocytes reprogramming by detaining cytosolic CK19 in intrahepatic cholangiocarcinoma[J]. Cell Death & Differentiation, 2025: 1-19.
IF=14.1 Kong X, Gu H, Zhang Y, et al. β‐Mangostin Attenuates TET2‐Mediated DNA Demethylation of Prkcg in the Prevention of Intervertebral Disc Degeneration[J]. Advanced Science, e05077.
IF=12.9 Zhu L, Tang Z, Jiang W, et al. Cholesterol biosynthesis induced by radiotherapy inhibits cGAS–STING activation and contributes to colorectal cancer treatment resistance[J]. Experimental & Molecular Medicine, 2025: 1-17.
IF=12.2 Li T, Wang H, Jiang Y, et al. LITTIP/Lgr6/HnRNPK complex regulates cementogenesis via Wnt signaling[J]. International Journal of Oral Science, 2023, 15(1): 33.
IF=10.2 Liao Z, Zhang L, Wu Z, et al. E0703 targets ERβ to facilitate the upregulation of GLI3, thereby alleviating irradiation-induced DNA damage on lymphocytes[J]. Cellular & Molecular Biology Letters, 2025, 30(1): 136.
IF=10.1 Li W, Ali T, Zheng C, et al. Anti-depressive-like behaviors of APN KO mice involve Trkb/BDNF signaling related neuroinflammatory changes[J]. Molecular Psychiatry, 2022, 27(2): 1047-1058.
|
|